Lactalis Nestlé Chilled Desserts UK will debut its Milkybar Gold White Chocolate Caramel Crème dessert, the first HFSS compliant crème dessert to market in the UK chilled desserts category
The dessert features the taste of Milkybar Gold confectionery, in a bar of creamy white chocolate and caramel flavor, at 91 calories per pot.
Christopher Pihoué, marketing manager at Lactalis Nestlé Chilled Desserts UK, described Milkybar Gold White Chocolate Caramel Crème dessert as having a unique flavor offering that will appeal to consumers”.
He added that with its calorie count and HFSS compliance, it brings a real USP in the chilled desserts aisle. The product will also capitalize on the trend towards gold chocolate product launches while attracting Milkybar confectionery fans to the chilled aisle.”
Milkybar Gold White Chocolate Caramel Crème Dessert is available in 2x65g at Tesco stores in the UK for an RRP of £1.50. A 4x65g variant will also be available beginning in July.


SMBC Eyes 20% VPBank Stake in Vietnam Expansion
Why a ‘rip-off’ degree might be worth the money after all – research study
US-Backed Pediatric HIV Treatment Drops After Foreign Aid Changes, Study Finds
U.S. Dollar Hits Two-Month High as Oil, Treasury Yields Surge
Office design isn’t keeping up with post-COVID work styles - here’s what workers really want
Fed Unveils Stablecoin Rules Under GENIUS Act
Erste Group Plans Tender Offer to Boost Poland Bank Stake
Stuck in a creativity slump at work? Here are some surprising ways to get your spark back
Disaster or digital spectacle? The dangers of using floods to create social media content
Solidigm Eyes $150 Billion IPO as SK Hynix Expands AI Storage Push
Akamai Shares Surge on $11.6B Anthropic AI Cloud Deal
Why financial hardship is more likely if you’re disabled or sick
US 10-Year Treasury Yield at 6% Emerges as New Market Risk Threshold
Alcohol is one of the most dangerous drugs, yet its presence is ubiquitous in social settings and celebrations
AstraZeneca Shares Sink After Wainua Trial Misses Key Heart Disease Goal 



